Dr. Neus Barrantes-Vidal presentation at the Schizophrenia Research Forum live webinar of July 6, 2015: http://www.schizophreniaforum.org/for/live/detail.asp?liveID=97
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Barrantes Vidal Schizotypy Webinar SRF
1. A Continuum View of Schizotypy
Dr. Neus Barrantes-Vidal
Universitat Autònoma de Barcelona (Spain)
University of North Carolina at Greensboro (US)
Sant Pere Claver – Fundació Sanitària (Spain)
CIBERSAM – Investigación Salud Mental en Red (Spain)
2. Dimensional Model of Schizotypy
Genetic variation x Environm. & Epigenetic? Factors
Nervous system type
Temperamental dispositions (Continuously inherited)
Individual
Differences Vulnerability to certain disorders
Adapted from Claridge (1985, 1997)
Schizotypy
Endophenotypes
Cognitive style / Personality traits
Personality
disorders
Psychosis
Psychosis
Spectrum
G x E
3. Clarifications about the Dimensional Model
Kelleher & Cannon (2011); Binbay et al. (2012); van Os (2009 & 2014); Zanvos et al. 2014; Barrantes-Vidal, Grant &
Kwapil (2015)
Shared sociodemographic and etiological risk factors
Familial clustering
Phenotypic continuity is not isomorphic with etiological continuity, but…
Differences in the effect size of some risk factors across the
continuum?? Continuum-threshold model?
S c h i z o t y p y
At risk syndromes
Schizotypal PD
Schizophrenia
Schizophreniform
Psychotic Experiences
Error measurement or
transdiagnostic
perspective?
4. Is this Relevant?
Healthy expression and advantageous features at the non-disordered low
end of the quantitative dimension of schizotypy (NOT “bening”
schizophrenia?!?), such as creativity (Mohr & Claridge, 2015; Power et al.,
2015)
Important to map both the positive as well as deleterious manifestations to
understand schizotypy and psychosis and to promote health and preventive
strategies in those with increasing risk (Barrantes-Vidal, 2014)